Krystal Biotech Inc
NASDAQ:KRYS

Watchlist Manager
Krystal Biotech Inc Logo
Krystal Biotech Inc
NASDAQ:KRYS
Watchlist
Price: 185.06 USD 0.46% Market Closed
Market Cap: 5.3B USD
Have any thoughts about
Krystal Biotech Inc?
Write Note

Balance Sheet

Balance Sheet Decomposition
Krystal Biotech Inc

Current Assets 713.2m
Cash & Short-Term Investments 588.3m
Receivables 97.3m
Other Current Assets 27.5m
Non-Current Assets 269.2m
Long-Term Investments 105.9m
PP&E 163.1m
Other Non-Current Assets 203k
Current Liabilities 89.5m
Accounts Payable 5.6m
Accrued Liabilities 80.8m
Other Current Liabilities 3.2m
Non-Current Liabilities 6.9m
Other Non-Current Liabilities 6.9m

Balance Sheet
Krystal Biotech Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
2
50
104
188
268
341
162
358
Cash Equivalents
2
50
104
188
268
341
162
358
Short-Term Investments
0
0
8
6
3
97
217
174
Total Receivables
0
0
0
0
0
0
0
42
Accounts Receivables
0
0
0
0
0
0
0
42
Other Receivables
0
0
0
0
0
0
0
0
Inventory
0
0
0
0
0
0
0
7
Other Current Assets
0
0
1
2
4
4
5
7
Total Current Assets
2
50
113
196
275
442
384
588
PP&E Net
0
0
3
11
34
120
170
168
PP&E Gross
0
0
3
11
34
120
170
168
Accumulated Depreciation
0
0
0
1
2
4
7
13
Long-Term Investments
0
0
0
1
0
64
5
62
Other Long-Term Assets
0
0
1
2
2
0
0
0
Total Assets
2
N/A
50
+2 177%
116
+132%
209
+80%
311
+49%
626
+102%
559
-11%
818
+47%
Liabilities
Accounts Payable
0
0
1
1
2
8
4
4
Accrued Liabilities
0
0
2
3
6
17
25
24
Short-Term Debt
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
0
Other Current Liabilities
0
0
0
0
8
0
0
4
Total Current Liabilities
0
1
3
3
16
26
29
33
Long-Term Debt
2
0
0
0
0
0
0
0
Other Liabilities
0
0
0
3
3
7
7
7
Total Liabilities
2
N/A
1
-68%
3
+383%
6
+110%
19
+208%
33
+74%
36
+11%
40
+10%
Equity
Common Stock
1
0
0
0
0
0
0
0
Retained Earnings
1
9
20
39
71
141
281
270
Additional Paid In Capital
0
59
133
242
363
735
804
1 048
Other Equity
0
0
0
0
0
0
1
1
Total Equity
0
N/A
50
+16 400%
113
+129%
203
+79%
292
+44%
594
+103%
522
-12%
779
+49%
Total Liabilities & Equity
2
N/A
50
+2 177%
116
+132%
209
+80%
311
+49%
626
+102%
559
-11%
818
+47%
Shares Outstanding
Common Shares Outstanding
9
10
14
17
20
25
26
28

See Also

Discover More